Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-independent Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00414388
What this trial is testing

Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 22
Testing effectiveness (Phase 2)Study completedNCT00081172
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00078585
What this trial is testing

PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Who this might be right for
Prostate Cancer
Bavarian Nordic 120
Testing effectiveness (Phase 2)Study completedNCT00012142
What this trial is testing

CCI-779 in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00113984
What this trial is testing

Vaccine and Antibody Treatment of Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01656304
What this trial is testing

Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Barbara Ann Karmanos Cancer Institute 16
Testing effectiveness (Phase 2)Ended earlyNCT00524589
What this trial is testing

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00417274
What this trial is testing

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Cancer
Cleveland BioLabs 31
Testing effectiveness (Phase 2)Study completedNCT00005857
What this trial is testing

Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Who this might be right for
Prostate Cancer
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00068731
What this trial is testing

Lycopene in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Ended earlyNCT00510224
What this trial is testing

Sandostatin for Patients With Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 13
Testing effectiveness (Phase 2)Study completedNCT00634647
What this trial is testing

Satraplatin and Prednisone to Treat Prostate Cancer

Who this might be right for
Prostate CancerGenetic Polymorphism
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00638378
What this trial is testing

Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Incyte Corporation 22
Testing effectiveness (Phase 2)Study completedNCT00878436
What this trial is testing

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 52
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Testing effectiveness (Phase 2)Study completedNCT05848011
What this trial is testing

Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Androgen-Independent Prostatic CancerAndrogen-Independent Prostatic NeoplasmsProstate Cancer Recurrent+6 more
MacroGenics 154
Testing effectiveness (Phase 2)Study completedNCT00390468
What this trial is testing

Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerPainProstate Cancer
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00260611
What this trial is testing

Study of Oxaliplatin and Taxotere in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Pittsburgh 34
Testing effectiveness (Phase 2)UnknownNCT00285675
What this trial is testing

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Who this might be right for
Androgen Independent Prostate Cancer (AIPC)Non Small Cell Lung Cancer (NSCLC)
Novacea 25
Testing effectiveness (Phase 2)Study completedNCT00134654
What this trial is testing

Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 48
Next Page